Site updated at Wednesday, 22 June 2016

Living with Dementia

Psychotic Symptoms

Acadia redesigns study on Parkinson’s psychosis drug

Acadia Pharmaceuticals Inc said it redesigned an ongoing late-stage study on its experimental anti-psychotic drug for Parkinson’s disease patients, and that it plans to conduct an identical study to win regulatory approval.

The redesigned study will include only patients from North America, and will exclude mildly psychotic patients, Acadia CEO Uli Hacksell said at… Acadia redesigns study on Parkinson’s psychosis drug   

Alzheimer’s Disease

neuronal degeneration1 - overeating1 - dementia and down’s syndrome1 - amyloid markers1 - esquirol1 - good sleep habits1 - hiv patients1 - motor deficits1 - sleep tied to alzheimer's1 - protein plaques1 - trichloroethylene1 - parkinson's disease protein1 - university of california2 - broken bones1 - mental impairment1 - management of delirium1 - merck1 - dopamine6 - muscle co-ordination1 - dementia screening1 - developing alzheimer's disease1 - sage test1 - progression of alzheimer's disease1 - misplacing items1 - memantine1 - dopamine-producing nerve cells1 - mental confusion4 - reconceptualization1 - dementia incident1 - hypomanic1 -